Merit Medical Systems, Inc.
General ticker "MMSI" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $5.1B (TTM average)
Merit Medical Systems, Inc. does not follow the US Stock Market performance with the rate: -23.2%.
Estimated limits based on current volatility of 1.6%: low 60.26$, high 62.16$
Factors to consider:
- Total employees count: 7400 (+6.5%) as of 2024
- China accounted for 11.0% of revenue in the fiscal year ended 2024-12-31
- US accounted for 59.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Supply chain disruptions, Geopolitical risks, Market competition, Litigation risks, Cybersecurity threats
- Current price 12.1% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [69.03$, 103.51$]
- 2026-12-31 to 2027-12-31 estimated range: [71.78$, 106.89$]
Financial Metrics affecting the MMSI estimates:
- Negative: with PPE of 22.9 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 12.19
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 4.57
- Positive: -14.17 < Investing cash flow per share per price, % of -4.76
- Positive: -9.55 < Industry operating profit margin (median), % of -3.62
- Positive: 42.59 < Shareholder equity ratio, % of 58.99 <= 64.29
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.51
- Positive: -0.02 < Operating cash flow per share per price, % of 5.73
Short-term MMSI quotes
Long-term MMSI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,257.37MM | $1,356.51MM | $1,515.91MM |
| Operating Expenses | $1,133.42MM | $1,200.82MM | $1,331.19MM |
| Operating Income | $123.94MM | $155.69MM | $184.72MM |
| Non-Operating Income | $-11.86MM | $-5.70MM | $-13.78MM |
| Interest Expense | $15.51MM | $31.22MM | $26.46MM |
| R&D Expense | $82.73MM | $87.47MM | $97.35MM |
| Income(Loss) | $112.09MM | $149.99MM | $170.94MM |
| Taxes | $17.68MM | $29.64MM | $42.45MM |
| Net Income(Loss)* | $94.41MM | $120.36MM | $128.49MM |
| Stockholders Equity | $1,202.00MM | $1,379.36MM | $1,584.30MM |
| Inventory | $303.87MM | $306.06MM | $333.70MM |
| Assets | $2,325.24MM | $2,418.60MM | $2,685.92MM |
| Operating Cash Flow | $145.15MM | $220.80MM | $297.37MM |
| Capital expenditure | $36.70MM | $38.04MM | $81.72MM |
| Investing Cash Flow | $-175.35MM | $-368.65MM | $-247.39MM |
| Financing Cash Flow | $559.27MM | $-60.01MM | $16.00MM |
| Earnings Per Share** | $1.64 | $2.07 | $2.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.